The awareness of centralized rectification in the pharmaceutical field is an inevitable requirement to promote the implementation of the Healthy China strategy, purify the ecology of the medical and health industry in our province, and safeguard the vital interests of the people.
Strengthening anti-corruption work in the pharmaceutical field is an important part of promoting the high-quality development of the pharmaceutical industry and an important part of improving the construction of the pharmaceutical governance system. Over the years, the National Health Commission, as the leading unit of the inter-ministerial joint mechanism to correct unhealthy practices in the field of pharmaceutical purchase and sales and medical services, has continuously strengthened the construction of industry style in conjunction with relevant departments, integrating system construction, system construction and the implementation of the nine principles of honest practice. In combination, we resolutely corrected unhealthy trends in the industry and achieved significant improvements.
With the historic achievements in comprehensively and strictly governing the party, building a clean and honest government, and fighting against corruption, the industry atmosphere in the pharmaceutical field continues to improve. But at the same time, the problem of corruption in the pharmaceutical field still exists, especially in recent years, where some "key minorities" and people in key positions have been investigated and punished for using their power to seek rents, accepting kickbacks, and offering and accepting bribes, which have seriously diluted the dividends of the reform and development of the pharmaceutical industry and eroded the dividends of the reform and development of the pharmaceutical industry. It affects the rights and interests of the people, affects the image of the industry, and harms the interests of the vast majority of people in the medical and health field.
The main principles of centralized rectification in the pharmaceutical field:
1. Comprehensive coverage and focus
This rectification covers the production, circulation, sales and use of the pharmaceutical industry , the entire chain of reimbursement, as well as all areas such as administrative departments in the pharmaceutical field, industry academic (associations), medical and health institutions, pharmaceutical production and operation enterprises, medical insurance funds, etc., to achieve full coverage of the pharmaceutical field. The focus of the rectification is on the "key few" and key positions, especially illegal behaviors such as using power in the pharmaceutical field to seek rent, "sales with gold", and profit transfer.
2. Focus on breakthroughs and corrective measures at the same time
Carry out key breakthroughs on corruption issues in the "key minority" and key positions, investigate, verify, handle and deal with key issues and typical cases. The report and analysis formed a high-pressure situation to focus on rectifying corruption in the pharmaceutical field across the country. Adhere to the combination of clue handling, problem rectification and industry governance, improve rules and regulations, improve governance mechanisms, standardize industry supervision, focus on strengthening the construction of long-term mechanisms, and achieve systematic, standardized and normalized governance of corruption issues in the pharmaceutical field.